Literature DB >> 3954620

Aneurysmal subarachnoid hemorrhage and viral infection. Lack of association.

T A Timmons, G A Donnan, J P Whisnant, C D Shelley, T F Smith.   

Abstract

We tested the hypothesis that intracranial aneurysm develops because of viral infection that produces arterial damage, and that aneurysmal rupture is related to viral infection. The following viral agents were studied: influenza A, influenza B, and respiratory syncytial viral titers, by the indirect immunofluorescence method, in 29 patients and 29 controls; herpes simplex virus titers, by immunofluorescence, in 31 patients and 31 controls; rubella viral titers (Rubazyme test), in 34 patients and 34 controls; and influenza A and B viral titers, by the complement fixation method, in 54 patients and 54 controls. Patients were selected on the basis of documented aneurysmal subarachnoid hemorrhage. Analysis, with derivation of the chi 2 method, to compare titer levels in patients and controls for each specific viral titer did not reveal positive correlations between the viral titers and aneurysmal subarachnoid hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954620     DOI: 10.1001/archneur.1986.00520040056019

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

1.  Intracranial aneurysm and HLA-DR2.

Authors:  W I Schievink; L P De Waal; L M Hageman; A J Van der Werf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

Review 2.  Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries.

Authors:  Julia Henry; Richard J Smeyne; Haeman Jang; Bayard Miller; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2010-07-21       Impact factor: 4.891

3.  COVID-19 and Intracranial Hemorrhage: A Multicenter Case Series, Systematic Review and Pooled Analysis.

Authors:  Moritz L Schmidbauer; Caroline Ferse; Farid Salih; Carsten Klingner; Rita Musleh; Stefan Kunst; Matthias Wittstock; Bernhard Neumann; Karl-Michael Schebesch; Julian Bösel; Jana Godau; Piergiorgio Lochner; Elisabeth H Adam; Kolja Jahnke; Benjamin Knier; Ingo Schirotzek; Wolfgang Müllges; Quirin Notz; Markus Dengl; Andreas Güldner; Oezguer A Onur; Jorge Garcia Borrega; Konstantinos Dimitriadis; Albrecht Günther
Journal:  J Clin Med       Date:  2022-01-25       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.